Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Swatantra Kumar, Rajni Nyodu, Vimal K. Maurya, et al.
Medical virology (2020), pp. 23-31
Open Access | Times Cited: 192

Showing 26-50 of 192 citing articles:

Coronavirus disease 2019 (Covid‐19) vaccination recommendations in special populations and patients with existing comorbidities
Zeinab Mohseni Afshar, Arefeh Babazadeh, Alireza Janbakhsh, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 3
Open Access | Times Cited: 37
Conformational dynamics of 13 amino acids long NSP11 of SARS-CoV-2 under membrane mimetics and different solvent conditions
Kundlik Gadhave, Prateek Kumar, Ankur Kumar, et al.
Microbial Pathogenesis (2021) Vol. 158, pp. 105041-105041
Open Access | Times Cited: 35
Development of an Inactivated Vaccine against SARS CoV-2
Shaikh Terkıs Islam Pavel, Hazel Yetişkin, Muhammet Ali Uygut, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1266-1266
Open Access | Times Cited: 34
3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: Validation as a Molecular Target, Proposal of a Novel Catalytic Mechanism, and Inhibitors in Preclinical and Clinical Trials
Vitor Martins de Freitas Amorim, Eduardo Pereira Soares, Anielle Salviano de Almeida Ferrari, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 844-844
Open Access | Times Cited: 5
Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection
Vimal K. Maurya, Swatantra Kumar, M L B Bhatt, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 4, pp. 1719-1735
Open Access | Times Cited: 38
Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic
Dimitriοs Vlachakis, Eleni Papakonstantinou, Τhanasis Mitsis, et al.
Food and Chemical Toxicology (2020) Vol. 146, pp. 111805-111805
Open Access | Times Cited: 37
The receptor binding domain of SARS-CoV-2 spike is the key target of neutralizing antibody in human polyclonal sera
Tara L. Steffen, E. Taylor Stone, Mariah Hassert, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 34
SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage
Mohsen Karami Fath, Abolfazl Jahangiri, Mahmoud Ganji, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 32
Enhancement of Antiviral Effect of Plastic Film against SARS-CoV-2: Combining Nanomaterials and Nanopatterns with Scalability for Mass Manufacturing
Yuyang Zhou, Nicola F. Fletcher, Nan Zhang, et al.
Nano Letters (2021) Vol. 21, Iss. 24, pp. 10149-10156
Open Access | Times Cited: 32
COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes
Mohammad A. I. Al-Hatamleh, Ma’mon M. Hatmal, Walhan Alshaer, et al.
European Journal of Pharmacology (2021) Vol. 896, pp. 173930-173930
Open Access | Times Cited: 27
Aspects About Science in the Context of Production and Communication of Knowledge of COVID-19
Poliana Flávia Maia, Rosária Justi, Monique Santos
Science & Education (2021) Vol. 30, Iss. 5, pp. 1075-1098
Open Access | Times Cited: 25
Human cell receptors: potential drug targets to combat COVID-19
Pawan Kumar Raghav, Keerthana Kalyanaraman, Dinesh Kumar
Amino Acids (2021) Vol. 53, Iss. 6, pp. 813-842
Open Access | Times Cited: 25
Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy
Amirmasoud Rayati Damavandi, Razieh Dowran, Sarah Al Sharif, et al.
Medical Microbiology and Immunology (2022) Vol. 211, Iss. 2-3, pp. 79-103
Open Access | Times Cited: 19
Enhanced sulfate pseudo-affinity chromatography using monolith-like particle architecture for purifying SARS-CoV-2
Kenji Kadoi, Junya Toba, Akiko Uehara, et al.
Vaccine (2025) Vol. 53, pp. 126951-126951
Open Access
Detection of IgG Antibodies Against COVID-19 N-Protein by Hybrid Graphene–Nanorod Sensor
Rafaela Boaventura, C. L. Pereira, Caroline Junqueira, et al.
Biosensors (2025) Vol. 15, Iss. 3, pp. 164-164
Open Access
Therapeutic Approaches for COVID-19: A Review of Antiviral Treatments, Immunotherapies, and Emerging Interventions
Maria João Vidal Alves, Ruana Carolina Cabral da Silva, Sérgio de Sá Leitão Paiva Júnior, et al.
Advances in Therapy (2025)
Open Access
Structural and molecular perspectives of SARS-CoV-2
Swatantra Kumar, Shailendra K. Saxena
Methods (2021) Vol. 195, pp. 23-28
Open Access | Times Cited: 21
Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs
Suvasmita Rath, Venkateswarlu Perikala, Atala Bihari Jena, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112095-112095
Open Access | Times Cited: 21
Deep learning-based molecular dynamics simulation for structure-based drug design against SARS-CoV-2
Yao Sun, Yanqi Jiao, Chengcheng Shi, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 5014-5027
Open Access | Times Cited: 15
Effect of acetic acid inactivation of SARS-CoV-2
Narayanappa Amruta, Nicholas J. Maness, Timothy E. Gressett, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0276578-e0276578
Open Access | Times Cited: 9
SARS-CoV-2 outbreak: role of viral proteins and genomic diversity in virus infection and COVID-19 progression
Hosni A. M. Hussein, Ali A. Thabet, Ahmed A. Wardany, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Nano-Crystallites of Ruthenium(III) Violurate Complex: Synthesis, Characterization, PXRD and DFT Structural Analysis. DNA/ HSA -Binding, Antiviral Activity Against COVID-19 and Molecular Docking Study
A. Alhadhrami
New Journal of Chemistry (2024) Vol. 48, Iss. 21, pp. 9718-9737
Closed Access | Times Cited: 3
A Microbiome-Driven Approach to Combating Depression During the COVID-19 Pandemic
Mahmoud A. Ghannoum, MaryKate Ford, Robert A. Bonomo, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 19
Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries
María Elena Romero-Ibarguengoitia, Arnulfo González-Cantú, Chiara Pozzi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Dynamic Link Prediction for Discovery of New Impactful COVID-19 Research Approaches
Xiangyu Wang, Yuan Li, Taiyu Ban, et al.
IEEE Journal of Biomedical and Health Informatics (2022) Vol. 26, Iss. 12, pp. 5883-5894
Closed Access | Times Cited: 14

Scroll to top